Growing complexities in the nature of human ailments is anticipated to fuel advanced healthcare research, culminating in the development of advanced assays
Growing complexities in the nature of human ailments is anticipated to fuel advanced healthcare research, culminating in the development of advanced assays
Award winning market research company Fact.MR is conducting an ongoing study on the global cell viability assays market. According to its findings, the market is poised to embark on an elevated growth trajectory through 2021, as heightened research and development activities to discover major breakthroughs in therapeutics come into the limelight. A robust expansion rate is on the cards for the 2021-2031 forecast period.
Heightening stem cell research activities have provided a massive nudge to the cell viability assays market in recent years, a trend which is expected to remain prevalent throughout the upcoming decade.
According to the US National Institute of Health, the government allocated nearly US$ 1.7 billion for stem cell research in 2018. International level collaborations in further stem cell research have also generated tailwinds for the cell viability assays market. For instance, in 2018, China and the United States collaborated to develop a new bio-link capable of bioprinting, culturing and expanding human induced pluripotent stem cells.
Growth is also being underpinned by surging prevalence of chronic diseases. According to the World Health Organization, chronic disease prevalence increased by nearly 60% in 2020. This number is further expected to climb to 29.4 million cases by 2040. Hence, manufacturers are scrambling to provide highly sophisticated viability assay kits, which is expected to provide major traction to market growth.
“Growing prevalence of cancers and cardiovascular ailments are prompting cell viability assay manufacturers to specialize in oncology and cardiac based assay testing kits, thereby attracting credible future investments within the domain,” says an analyst at Fact.MR
Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=2678
Key Takeaways
- DNA synthesis proliferation assays to remain the top selling category
- Accelerating research in developing advanced therapeutic approaches to enhance uptake across the US
- UK to attract high volumes of investments, attributed to rising funding for developing synthetic biology
- Germany and France to experience high growth, amid increasing importance on furthering stem cell research
- India & China to pivot expansion trajectory across the Asia-Pacific region
Cell Viability Assays Market- Prominent Drivers
- Increasing stem cell research for discovering advanced therapeutic approaches to heighten cell viability assay sales
- Opportunities are especially lucrative in the cancer and heart disease segments, owing to their rising prevalence
- Preference for automated assay testing is prompting manufacturers to introduce smart cell viability assay solutions
Cell Viability Assays Market- Key Restraints
- High costs of procuring equipment likely to prevent small-scale healthcare settings from adopting cell viability assay kits
- Constant technological upgrades leads to additional expenditure on upgrading existing kits
Discover more about the cell viability assays market with figures, data tables and the table of contents. You will also find detailed market segmentation on https://www.factmr.com/report/2678/cell-viability-assays-market
Competitive Landscape
Merck & Co., Promega Corporation, Geno Technology Inc., Thermo Fisher Scientific, BD Biosciences, BI Biological Industries, Promo Cell and Abnova Millipore are some key cell viability assays manufacturers operating in the global landscape. Leveraging partnerships with key hardware and software solutions providers to develop highly advanced viability assay solutions.
In September 2020, Promega Corporation, in collaboration with Hitachi High-Tech, launched its benchtop capillary electrophoresis (CE) instrument known as the Spectrum Compact CE System, an integrated DNA analysis instrument enabling scientists to perform Sanger sequencing and fragment analysis on the bench.
Furthering research to develop new assays is another approach adopted by players to deepen their presence. For example, Geno Technology Inc. offers a wide range of protein research products, including qualification assays, extraction & lysis systems, fractionation & enrichment kits and folding & stabilization solutions among others.
More Insights on the Cell Viability Assays Market
In its latest report, Fact.MR offers unbiased analysis of the global cell viability assays market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (dye reduction assays, mitochondrial membrane function assays, imaging microbial viability assays, DNA synthesis proliferation assays, microplate assays and others) and end user (hospitals, laboratory research center, diagnostic research center and pharmaceutical research center) across seven regions (North America, Latin America, Western Europe, Eastern Europe, Japan, APEJ and Middle East & Africa)
For critical insights on this market, request for More Info
https://www.factmr.com/connectus/sample?flag=RM&rep_id=2678
Explore Fact.MR’s Coverage on the Healthcare Domain
Endoscopic Clips Market: A detailed assessment of global endoscopic clips market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in Fact.MR’s extensive coverage on the landscape. The report analyses the key drivers, trend and opportunities expected to shape future trajectory of the market.
Geriatric Medicines Market: Fact.MR’s geriatric medicines market report offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales across the globe. Fact.MR has studied the global geriatric medicines market with detailed segmentation across prominent geographies.
Medical Mask Market: Fact.MR published a market study on the global market for medical mask. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities, and restraints, as well as detailed information about the medical mask market structure.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Sudip Saha
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583